Anvisa updates form for importing Cannabis-derived products

Anvisa (National Health Surveillance Agency), Brazil’s regulatory body, has announced an update to the import form for Cannabis-derived products via express shipment, used in the Solicita system for individuals importing products for personal use.

From October 1st, 2024, the system will automatically validate fields related to the “Import Authorization Number,” “Patient CPF,” and “Commercial Name of the Imported Product.” This will make the process more agile and secure, preventing errors during completion and facilitating the import process.

If the import authorization number entered is incorrect or invalid, the system will notify the user. Should corrections be required, the user must submit a new request, specifying the necessary changes. All instructions for filling out the form will be available in the Manual for Express Shipment Requests and the Solicita User Manual.

This is an important step in optimizing the regulatory process and ensuring user safety. The automation and validation of key fields in the form minimize the occurrence of errors, saving time and reducing the risk of delays in the treatment of patients who rely on these products.

This improvement directly impacts process efficiency, which is especially relevant for companies dealing with Cannabis products in Brazil. Specialized support to navigate the complexity of this system can be decisive for importers, distributors, and patients to face less bureaucracy and experience faster and more efficient processes.

If you need more information on regulatory issues for cannabis products, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

Contact us

We will contact you as soon as possible.